Anti-FZD2 ADCC Enhanced Antibody is an ADCC enhanced antibody produced by our Afuco™ platform. The antibody specifically bind Fzd2, and may promote internalization of the Fzd2 receptor by the cancer cells and/or prevent ligand binding to Fzd2. It is used for treatment of specific cancers such as late stage hepatocellular carcinoma.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.